Breast Pathology and Immunohistochemistry

Immunohistochemistry is a special staining process performed on fresh or frozen breast cancer tissue removed during biopsy. IHC is used to show whether or not the cancer cells have HER2 receptors and/or hormone receptors on their surface. This information plays a critical role in treatment planning. Immunohistochemistry (IHC) is used to characterize intracellular proteins or various cell surfaces in all tissues. Individual markers, or more often panels of various marker proteins, can be used to characterize various tumor subtypes, confirm tissue of origin, distinguish metastatic from primary tumor, and provide additional information which may be important for prognosis, predicting response to therapy, or evaluating residual tumor post-treatment. There is a growing list of available antibodies, which contribute to the broader utility of immunohistochemistry for solving diagnostic problems or for determining prognosis and response to therapy in breast pathology.

    Related Conference of Breast Pathology and Immunohistochemistry

    September 24-25, 2020

    Global Digital Pathology Summit

    Paris, France
    October 05-06, 2020

    2nd World Congress on Pathology and Clinical Practice

    Vienna, Austria
    October 19-20, 2020

    World Congress on Pathology and Microbiology

    Manila, Philippines
    October 19-20, 2020

    Global Pathologists Meet

    Manila, Philippines
    November 25-26, 2020

    18th Asia Pacific Pathology Congress

    Tokyo, Japan
    November 25-26, 2020

    World Congress on Histopathology & Cytopathology

    Kyoto, Japan
    December 07-08, 2020

    7th Annual Meet on Cardiology and Heart diseases

    Prague, Czech Republic

    Breast Pathology and Immunohistochemistry Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in